Experience

Stibbe advises Forbion Capital Partners

Stibbe advises Forbion Capital Partners

Stibbe advises Forbion Capital Partners

17.02.2012 NL law

Advising Forbion Capital Partners on the delisting of Amsterdam Molecular Therapeutics (AMT) Holding.

Team

Related experience

Our website uses functional cookies for the functioning of the website and analytic cookies that enable us to generate aggregated visitor data. We also use other cookies, such as third party tracking cookies - please indicate whether you agree to the use of these other cookies:

Privacy – en cookieverklaring